Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 20, 2017 09:00 ET | Source: Active Biotech

Active Biotech lämnar uppdaterad information om bolagets finansiella ställning

PRESSMEDDELANDE Active Biotech har erhållit en waiver (undantag) från sitt åtagande gentemot den bank som finansierar bolagets fastighet i Lund att alltid ha en lägsta likviditet av minst 30...
December 20, 2017 09:00 ET | Source: Active Biotech

Active Biotech provides updated information about the company's financial position

PRESS RELEASE Active Biotech has received a waiver (exemption) from its commitment to the bank that finances the company's property in Lund that the company's liquidity should never fall below SEK...
December 07, 2017 13:00 ET | Source: Active Biotech

Active Biotech lämnar uppdaterad information om bolagets finansiella ställning - bolaget har i nuläget inte finansiering för verksamheten för den kommande tolvmånadersperioden

PRESSMEDDELANDE Active Biotech (Nasdaq Stockholm: ACTI) lämnar uppdaterad information om bolagets finansiella situation. Som framgick av bolagets delårsrapport för januari-september 2017 har...
December 07, 2017 13:00 ET | Source: Active Biotech

Active Biotech provides updated information about the company's financial position - the company currently lacks funding to ensure its operations for the coming twelve-month period

PRESS RELEASE Active Biotech (Nasdaq Stockholm: ACTI) provides updated information about the company's financial situation. As informed by the company in the interim report for January-September...
December 01, 2017 07:00 ET | Source: Active Biotech

Active Biotech tillkännager data från fas II-studien ARPEGGIO med laquinimod

PRESS RELEASE Active Biotech (Nasdaq Stockholm: ACTI) tillkännagav idag inledande resultat från fas II-studien av laquinimod i Primär Progressiv MS (PPMS), sponsrad av Active Biotechs partner...
December 01, 2017 07:00 ET | Source: Active Biotech

Active Biotech announce results in ARPEGGIO Phase II trial with laquinimod in Primary Progressive MS

PRESS RELEASE Active Biotech (Nasdaq Stockholm: ACTI) today announced initial results from the Phase II proof of concept study of laquinimod in Primary Progressive MS (PPMS) sponsored by Active...
November 17, 2017 02:30 ET | Source: Active Biotech

Active Biotechs valberedning utsedd

PRESSMEDDELANDE Enligt beslut från årsstämman den 15 juni 2017, ska valberedningen för Active Biotech bestå av representanter för de, i slutet av september månad 2017, tre största ägarna, samt...
November 17, 2017 02:30 ET | Source: Active Biotech

Active Biotech's election committee appointed

PRESS RELEASE In accordance with a decision made by the Annual General Meeting held on 15 June, 2017, the Election Committee shall comprise the representatives for the three largest shareholders,...
November 09, 2017 02:30 ET | Source: Active Biotech

Active Biotech AB - Delårsrapport januari - september 2017

Kvartal 3 i korthet Bolagets ansökan avseende en av patentfamiljerna inom SILC-projektet har beviljats patent i USA Prekliniska data för en SILC-substans publicerades i den vetenskapliga...
November 09, 2017 02:30 ET | Source: Active Biotech

Active Biotech AB - Interim report January - September 2017

Third quarter in brief The company's application related to one of the patent families in the SILC project was granted patent in the US Preclinical data for a SILC substance was published...